Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals
Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals
复制标题
DOI:
10.1128/iai.72.1.332-337.2004
复制
发表时间:
2004-01-01
影响因子:
3.1
通讯作者:
Borrow, R
中科院分区:
文献类型:
--
作者:
Balmer, P;Falconer, M;Borrow, R
Asplenic individuals are known to be at increased risk of infection with encapsulated bacteria. Recent United Kingdom recommendations stated that this at-risk group should receive one dose of the meningococcal serogroup C conjugate (MCC) vaccine. However, the immune response of asplenic individuals to MCC vaccine is unknown. The immune response of asplenics (n = 130) to immunization with the MCC vaccine was investigated. Asplenic individuals had a significantly lower geometric mean titer (GMT) (157.8; 95% confidence interval [CI], 94.5 to 263.3) of bactericidal antibody in serum (SBA) than an age-matched control group (n = 48) (1448.2; 95% CI, 751.1 to 2792.0). However, 80% of asplenic individuals achieved the proposed protective SBA titer of greater than or equal to8. No differences were observed between the two groups in the serogroup C-specific immunoglobulin G geometric mean concentration. A significant reduction in SBA GMT or the number of responders achieving an SBA titer of greater than or equal to8 was observed if the reason for splenectomy was a medical cause or if MCC vaccination occurred